Quantum dot-based biotracking and biodetection.

Li-Juan Zhang,Li Xia,Hai-Yan Xie,Zhi-Ling Zhang,Dai-Wen Pang
DOI: https://doi.org/10.1021/acs.analchem.8b04721
IF: 7.4
2019-01-01
Analytical Chemistry
Abstract:Quantum dots (QDs) are a kind of quasi-zero-dimensional semiconductor nanocrystal, with a radius smaller than or close to their exciton Bohr radius. In 1977, Katzschmann observed the anomalous luminescence of particles with 1-5 nm size composed of II-VI family elements and proposed a relationship between band gap and particle size.1 This is the earliest report about QDs and quantum size effect. In the early 1980s, Elimov, Efros and Brus did a great deal of pioneering work on the quantum size effect in semiconductor nanocrystals.2-4 In 1986, Reed named the nanocrystals with quantum size effect and zero degree of freedom as quantum dot.5 During the 1990s, QDs attracted more attentions and developed rapidly. Importantly, Bawendi produced QDs with uniform size and shape,6 and Guyot-Sionnest obtained strongly luminescent cadmium selenide/zinc sulfide (CdSe/ZnS) QDs by capping CdSe QDs with ZnS,7 which are the first core-shell QDs. Production of high-quality QDs greatly promoted the application of this new type of materials. In 1998, Nie and Alivisatos transferred QDs from oil phase to aqueous phase and conjugated them to biomolecules to prepare fluorescent probes for imaging cellular structures.8,9 They unprecedentedly introduced QDs to biological fields, opening a new chapter for QD development.
What problem does this paper attempt to address?